caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1982697371

John LamondMD

PRACTICEHEALTH ACCESS NETWORKSee all providers at this practice →
Radiation OncologyUpland, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where John Lamond's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
CROZER-CHESTER MEDICAL CENTER851,101
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
43224
DELAWARE COUNTY MEMORIAL HOSPITAL31154
Suman Tiwari
Radiation Oncology · Pottstown, PA
28291
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
20128
Stephen Arrigo
Radiation Oncology · King Of Prussia, PA
15125
Christina Clay
Internal Medicine · Camden, NJ
1360
Rashmi Sanjay
Hematology-Oncology · Ridley Park, PA
11218
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
604
Unique beneficiaries
—
Total services
1,558
Distinct HCPCS
15
Medicare payment
$100K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 296 Radiation Oncology providers in PA — above median (cohort median 1,328).
PRESCRIBING · PART D · 2024
Total Rx claims
57
Beneficiaries
—
Total drug cost
$39K
Distinct drugs
3
Brand share
26.3%
Top prescribed drugs
Tamsulosin Hcl31 claims
Relugolix15 claims
Mometasone Furoate11 claims
QUALITY · MIPS · 2024
Final MIPS score
85.5
Quality
98.7
Cost
47.4
Improvement activities
40.0
Promoting interop.
98.0
Payment adjustment
0.44%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$31
Payment records
1
By payment type
Food and Beverage$31
Top paying entities
Food and Beverage$31